Dcprime B.V.
Records under this name other than patents Dcprime B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Dcprime B.V.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,470,789 | Method for inducing and accelerating cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,027,001 | Therapeutic cancer vaccines derived from a novel dendritic cell line Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,064,923 | Therapeutic cancer vaccines derived from a novel dendritic cell line Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,071,778 | Combination product for use in tumor vaccination Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,052,144 | Methods of tumor vaccination Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,091,681 | Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,364,758 | Use of leukemia-derived cells in ovarian cancer vaccines Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,397,055 | Methods of tumor vaccination Formerly held In force · From the USPTO record | In force | From the USPTO record |